Premium
Enhanced Expression of Indoleamine 2,3‐Dioxygenase in Helicobacter pylori ‐Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin 17 Production
Author(s) -
Larussa Tiziana,
Leone Isabella,
Suraci Evelina,
Nazionale Immacolata,
Procopio Teresa,
Conforti Francesco,
Abenavoli Ludovico,
Hribal Marta L.,
Imeneo Maria,
Luzza Francesco
Publication year - 2015
Publication title -
helicobacter
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 79
eISSN - 1523-5378
pISSN - 1083-4389
DOI - 10.1111/hel.12174
Subject(s) - helicobacter pylori , indoleamine 2,3 dioxygenase , gastric mucosa , immune system , gastritis , immunology , medicine , biopsy , blot , interleukin 10 , stomach , biology , gene , tryptophan , amino acid , biochemistry
Background Indoleamine 2,3 dioxygenase ( IDO ) interferes with immune responses. Host immune response against Helicobacter pylori is involved in the persistence of the infection and its related diseases. Aim To investigate the role of IDO in the regulation of Th1/Th2 and Th17 pathways in H. pylori infection. Methods Gastric biopsy samples were taken from 42 patients who underwent endoscopy and evaluated for the expression of IDO by Western blotting. Gastritis was assessed by the Sydney system score. In a subgroup of patients, biopsies were treated with the IDO inhibitor 1‐methyl‐L‐tryptophan and the expression of interferon‐γ (IFN‐γ) mRNA and that of T‐bet, interleukin‐17 (IL‐17), and IL‐4 determined by real‐time PCR and Western blotting, respectively. Results IDO expression was found to be enhanced ( p = .001) in gastric biopsies from H. pylori ‐infected (n = 18) compared with uninfected (n = 24) patients. Levels of IDO expression were inversely related to the gastritis score ( r = −.684, p = .002) in H. pylori ‐infected gastric mucosa, but not in uninfected mucosa. In gastric biopsy cultures, IDO inhibition increased the expression of IFN‐γ mRNA ( p = .014), T‐bet ( p = .045), and IL‐17 ( p = .02) while decreasing that of IL‐4 ( p = .048). Conclusions In H. pylori ‐infected human gastric mucosa, an enhanced expression of IDO is capable of modulating Th1/Th2 and Th17 pathways. This mechanism lowers gastric inflammation, possibly contributing to the persistence of H. pylori . Targeting the IDO pathway may be a new strategy for modulating H. pylori ‐induced mucosal immune response.